Filter
2900
Filtered Results: 2900
Text search:
Centers
of
Disease
Controle
CDC
Featured
Recommendations
305
New Publications
742
Language
Document type
No document type
1536
Guidelines
459
Studies & Reports
355
Manuals
145
Fact sheets
137
Strategic & Response Plan
103
Training Material
56
Infographics
35
Situation Updates
25
Resource Platforms
24
Brochures
14
Online Courses
7
Dashboards/Maps
2
Videos
2
Countries / Regions
Global
110
Africa
107
Sierra Leone
103
Liberia
94
Nigeria
77
India
75
Ethiopia
73
West and Central Africa
71
Kenya
70
Congo, Democratic Republic of
63
East and Southern Africa
59
Western and Central Europe
57
Guinea
56
Middle East and North Africa
55
Senegal
51
Uganda
50
Rwanda
47
Ghana
40
Tanzania
39
Mozambique
39
Latin America and the Carribbean
39
Zambia
38
Malawi
35
Burkina Faso
34
Haiti
34
South Africa
34
Namibia
33
Côte d’Ivoire / Ivory Coast
29
Guinea-Bissau
28
South Sudan
28
Bangladesh
27
Mali
26
Syria
25
Russia
25
Brazil
24
Ukraine
24
Cameroon
23
Zimbabwe
22
Germany
22
Cambodia
21
Nepal
20
Colombia
20
Yemen
20
USA
19
Chad
19
Angola
19
Eastern Europe
19
Niger
18
Madagascar
17
Philippines
12
Indonesia
12
Eastern Europe and Central Asia
12
Asia
12
Botswana
10
Vietnam
10
Eswatini/ Swaziland
9
Lesotho
9
Myanmar / Burma
8
South–East Asia Region
8
Paraguay
8
Ecuador
7
Pakistan
6
Togo
5
Benin
5
Venezuela
5
France
5
Afghanistan
4
Egypt
4
Thailand
4
Chile
4
Western Pacific Region
4
Laos
4
North America
4
Spain
4
Saudi Arabia
3
Turkey
3
Gambia
3
China
3
Sudan
3
Central African Republic
3
Peru
3
Portugal
3
Somalia
2
Iraq
2
Lebanon
2
Argentina
2
North Macedonia
2
Burundi
2
Bolivia
2
Mexico
2
Congo-Brazzaville
2
Timor Leste/ East Timor
2
Estonia
2
Gabon
2
Jamaica
2
Mauritius
2
Tunisia
2
Morocco
1
Malaysia
1
Dominican Republic
1
Honduras
1
Cape Verde
1
Sri Lanka
1
Bhutan
1
Palestine
1
Italy
1
Albania
1
Armenia
1
Southern Africa
1
Tajikistan
1
Qatar
1
Bulgaria
1
Romania
1
Moldova
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Georgia
1
Uruguay
1
Turkmenistan
1
Japan
1
Belgium
1
United Kingdom
1
South Korea
1
Morocco
1
Authors & Publishers
Publication Years
Category
Countries
1082
Clinical Guidelines
235
Public Health
146
Key Resources
127
Women & Child Health
82
Pharmacy & Technologies
47
Capacity Building
40
Toolboxes
COVID-19
486
HIV
237
Ebola
235
TB
214
Rapid Response
165
AMR
156
NTDs
79
Zika
77
Mental Health
69
NCDs
69
Planetary Health
54
Caregiver
51
Cholera
42
Refugee
37
Specific Hazards
30
Polio
28
Pharmacy
26
Natural Hazards
25
Conflict
23
Disability
19
Global Health Education
18
Health Financing Toolbox
12
Social Ethics
1
A printable copy of the article published in Morbidity and Mortality Weekly Report (MMWR) can be found on the CDC Homepage. Follow the Download Link for redirection to ....
Childhood Respiratory Diseases & the Environment learning objectives
•To understand how the respiratory tract is affected by the environment
•To describe respiratory diseases linked to the ...
Rabies remains an under-reported neglected zoonosis with a case-fatality rate of almost 100% in humans and animals. Dog-mediated human rabies causes tens of thousands ... human deaths annually despite being 100% preventable. More than 95% of human cases are caused by the bite of a rabies-infected dog. Dog-mediated human rabies disproportionately affects rural communities, particularly children, and economically disadvantaged areas of Africa and Asia, where awareness of the disease and access to appropriate post-exposure prophylaxis (PEP) can be limited or nonexistent.
There has been no systematic comparison of how the policy response to past infectious disease outbreaks and epidemics was funded. This study aims to collate and analyse funding for the Ebola epidemi...
N95 or equivalent respirators are single-use personal protective equipment (PPE) designed for use by health workers that provide direct care to patients with diseases transmitted by aerosols or during aerosol generating procedures (AGP) for patients...
Bioethics 519 (online) doi:10.1111/bioe.12145 Volume 29 Number 8 2015 pp. 488–596;
Pandemic plans recommend phases of response to an emergent infectious disease (EID) outbreak, and are primarily...
Prevention, identification and management of health worker infection in the context of COVID-19
recommended
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, in...
This topic last updated: Apr 28, 2020.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care pr...
This topic last updated: Apr 28, 2020.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care pr...
This topic last updated: Apr 28, 2020.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care prof...
This document provides interim guidance on the prevention, identification and management of health worker infection in the context of COVID-19. It is intended for occupational health departments, in...
At this time, information about COVID-19 is rapidly evolving as new details are confirmed and new questions emerge. In the
event of an outbreak in your community, as a parent/caregiver, your first concern is about how to protect and take care ...
your children and family. Knowing important information about the outbreak and learning how to be prepared can reduce your
stress and help calm likely anxieties. This resource will help you think about how an infectious disease outbreak might affect
your family—both physically and emotionally—and what you can do to help your family cope.
Updated on 6 APRIL 2020
There are serious concerns that the situation might escalate in the next weeks modelling the epi curve of other regions. The interlinkages between human mobility and the current pandemic ... COVID-19 are well established, and while international flights have been suspended in the region, the porous borders on land and water crossings remain difficult to control.
WHO‘s Global Strategy to Accelerate the Elimination of Cervical Cancer, launched today, outlines three key steps: vaccination, screening and treatment. Successful implementation of all three could...
R4D conducted a thorough desk review and qualitative fiscal space analysis, 19 interviews about financing for the three diseases and the extent of alignment between public financial management syste...
In 2015, 5.9 million children under age five died (1). The major causes of child deaths globally are pneumonia, prematurity, intrapartum-related complications, neonatal sepsis, congenital anomalies, diarrhoea, injuries and malaria (2). Most ... these diseases and conditions are at least partially caused by the environment. It was estimated in 2012 that 26% of childhood deaths and 25% of the total disease burden in children under five could be prevented through the reduction of environmental risks such as air pollution, unsafe water, sanitation and inadequate hygiene or chemicals.
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and ... NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply, including trends in the cultivation of coca bush and in the manufacture of and trafficking in cocaine at the global level and in the various regions. An analysis of different eradication strategies is included, as well as of the role of women in the cocaine supply chain. The chapter also presents the latest estimates of and trends in cocaine use, including a brief introduction to the various cocaine consumer products. Finally, it reviews the trends in the use of cocaine and the impact of the coronavirus disease (COVID-19) pandemic in different regions
This Review summarizes many of the persistent biological alterations associated with childhood maltreatment including changes in neuroendocrine and neurotransmitter systems and pro-inflammatory cytokines in addition to specific alterations in brain ...
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment ... people infected with the Ebola virus:
BCX4430 (Biocryst);
Brincidofovir (Chimerix);
Favipiravir (Fujifilm Corporation/Toyama);
TKM-100802 (Tekmira);
AVI-7537 (Sarepta);
ZMapp (Leafbio Inc.);
Anti-Ebola F(ab’)2 (Fab’entech).
The amount of information available for the seven treatments is highly variable. For some compounds there is no data from use in human subjects available. A small number of treatments have been administered to patients in the current Ebola outbreak as compassionate use. Finally, there are also medicines included in this review that have already been studied in humans, albeit for the treatment of other viral diseases.
This report investigates the impact of potential misclassification of samples on HIV prevalence estimates for 23 surveys conducted from 2010-2014. In addition to visual inspection ... laboratory results, we examined how accounting for potential misclassification of HIV status through Bayesian latent class models affected the prevalence estimates. Two types of Bayesian models were specified: a model that only uses the individual dichotomous test results and a continuous model that uses the quantitative information of the EIA (i.e., the signal-to-cutoff values). Overall, we found that adjusted prevalence estimates matched the surveys’ original results, with overlapping uncertainty intervals. This suggested that misclassification of HIV status should not affect the prevalence estimates in most surveys. However, our analyses suggested that two surveys may be problematic. The prevalence could have been overestimated in the Uganda AIDS Indicator Survey 2011 and the Zambia Demographic and Health Survey 2013-14, although the magnitude of overestimation remains difficult to ascertain. Interpreting results from the Uganda survey is difficult because of the lack of internal quality control and potential violation of the multivariate normality assumption of the continuous Bayesian latent class model. In conclusion, despite the limitations of our latent class models, our analyses suggest that prevalence estimates from most of the surveys reviewed are not affected by sample misclassification.
